Patent Assignment
Reel/Frame 020299/0814
Change of Name
Recorded: 2007-12-31
Pages: 3
Assignor
DELTA BIOTECHNOLOGY LIMITED
Executed: 2006-07-14
Assignee
NOVOZYMES DELTA LIMITED
CASTLE COURT, 59 CASTLE BOULEVARD, NOTTINGHAM, NG7 1FD, UNITED KINGDOM
Covered Properties
(13)
Novel Biologically Active Polypeptides, Preparation Thereof and Pharmaceutical Composition Containing Said Polypeptides
Application:
08/256,927 →
Fusion Polypeptides Comprising Human Serum Albumin,Nucleic Acids Encoding Same,and Recombinant Expression Thereof
Patent:
5,876,969 →
Application:
08/797,689 →
Novel Biologically Active Polypeptides, Preparation Thereof and Pharmaceutical Composition Containing Said Polypeptides
Application:
09/258,532 →
Fusion Polypeptides of Human Serum Albumin and a Therapeutically Active Polypeptide
Hormone and Albumin Fusion Protein
G-Csf and Albumin Fusion Protein
Interleukin and Albumin Fusion Protein
Interferon and Albumin Fusion Protein
Insulin and Albumin Fusion Protein
Methods of Treatment with Erythropoietin and Albumin Fusion Protein
Erythropoietin and Albumin Fusion Protein, Nucleic Acids, and Met Hods Thereof
Methods of Treatment with Interferson and Albumin Fusion Protein
Fusion Polypeptides of Human Serum Albumin and a Therapeutically Active Polypeptide
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 28, 1994
From: FLEER, REINHARD; FOURNIER, ALAIN; GUITTON, JEAN-DOMINIQUE; JUNG, GERARD
To: RHONE-POULENC RORER S.A.
Reel/Frame 007181/0583 →
Contract
Mar 1, 2002
From: RHONE-POULENC RORER S.A.
To: CENTEON L.L.C.
Reel/Frame 012653/0458 →
Change of Name
Mar 11, 2002
From: CENTEON L.L.C.
To: AVENTIS BEHRING L.L.C.
Reel/Frame 012698/0406 →
Assignment of Assignor's Interest
Jul 11, 2006
From: AVENTIS BEHRING L.L.C.
To: DELTA BIOTECHNOLOGY LTD.
Reel/Frame 017921/0492 →
Change of Name
Dec 31, 2007
From: NOVOZYMES DELTA LIMITED
To: NOVOZYMES BIOPHARMA UK LIMITED
Reel/Frame 020299/0491 →
Corrective Assignment to Correct the U.S. Patent No. 6,686,179 Was Erroneously Typed as U.S. Patent No. 6,684,179 Previously Recorded on Reel 020299 Frame 0491. Assignor(S) Hereby Confirms the Change of Name.
May 30, 2008
From: NOVOZYMES DELTA LIMITED
To: NOVOZYMES BIOPHARMA UK LIMITED
Reel/Frame 021018/0539 →
Corrective Assignment to Correct the U.S. Patent No. 6,686,179 Was Erroneously Typed as U.S. Patent No. 6,684,179 Previously Recorded on Reel 017921 Frame 0492. Assignor(S) Hereby Confirms the Change of Name.
May 30, 2008
From: AVENTIS BEHRING L.L.C.
To: DELTA BIOTECHNOLOGY LIMITED
Reel/Frame 021018/0510 →
Corrective Assignment to Correct the U.S. Patent No. 6,686,179 Was Erroneously Typed as U.S. Patent No. 6,684,179 Previously Recorded on Reel 020299 Frame 0814. Assignor(S) Hereby Confirms the Change of Name.
May 30, 2008
From: DELTA BIOTECHNOLOGY LIMITED
To: NOVOZYMES DELTA LIMITED
Reel/Frame 021018/0534 →
Assignment of Assignor's Interest
Oct 7, 2010
From: NOVOZYMES BIOPHARMA UK LIMITED
To: NOVOZYMES BIOPHARMA DK A/S
Reel/Frame 025105/0517 →